Navigation Links
Farm Bill Provision Will Disrupt Arkansas Medicaid Program
Date:2/29/2008

Over 40 million Needy Children and Adults to be Affected Nationwide, Study

Expects

WASHINGTON, Feb. 29 /PRNewswire-USNewswire/ -- A survey released today by Spectrum Science Communications states that a little known anti-privatization measure in the current farm bill would critically harm Arkansas' ability to effectively administer its Medicaid program. The measure, offered as an amendment to the House-passed Farm Bill by Rep. Joe Baca (D-CA), would restrict all states from using non-profits and other private organizations in the administration of public assistance programs.

Over 40 million needy children and adults would be affected by the disruptions in service that would occur if the federal government takes away states' ability to partner with private firms and non-profit groups. Among those who would be affected are over 14 million enrollees in the Medicaid and The State Children's Health Insurance Programs (SCHIP), 26 million food stamp recipients, and 1.9 million participants in the Temporary Assistance for Needy Families (TANF) program.

"This provision will severely hamper the administration of hundreds of social services programs in the U.S., affecting 700,000 recipients of Medicaid services in Arkansas," said Audrey Spolarich of Spectrum Science Communications.

The Spectrum study found that states such as Arkansas rely on non- government organizations to assist in the administration of many means-tested social service programs, such as the Food Stamp program. The East Arkansas Family Health Center, a non-profit organization, helps identify and enroll citizens for the state's Food Stamp program, which helps nearly 385,000 low- income Arkansans purchase food.

"As someone who has had to administer these programs to recipients, I can tell you first-hand how adversely impacted state governments will be if this provision passes," said former South Carolina Governor Jim Hodges. "In South C
'/>"/>

SOURCE Spectrum Science Communications
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Farm Bill Provision Will Disrupt Arizona Child Support Enforcement Program
2. Leading Asbestos-Cancer Group Urges Congress to Partner with Them and Support Funding Provisions in Asbestos Ban Legislation
3. Blue Cross Blue Shield of Michigan Says Guaranteed Access Provisions of Insurance Reform Bills Protect Michigan Consumers Twice-Over
4. NCPA Applauds Pharmacy TRICARE Provisions in the Congressional Passage of the Defense Authorization Bill
5. NCPA Statement Urging Congress to Include Pharmacy Provisions in Medicare-Medicaid Legislation
6. Connecticut Bishops Back Down over Provision of Emergency Contraception
7. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
8. Colorado Medical School Receives Provisional Accreditation
9. Teamsters Warn of Possible Work Stoppages, Service Disruptions at AmerisourceBergen
10. TV Could Be Disrupting Your Kids Sleep
11. How DDT metabolite disrupts breast cancer cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ewswire-USNewswire/ -- Pro-abortion activists will...r campaign against the U.S. House bill,s pro-life ...r Life President and CEO Charmaine Yoest released ... effort to expand taxpayer funding of abortion: ,...eminist groups and the abortion lobby actually dem...
(Date:12/2/2009)...ton Post Highlights Dangers ,, WASHINGTON, ...ic bishops have their way, many medical treatments... be under threat. The pressure that the US bishop...re reform has been widely reported. An ad in this ...pact if that pressure to influence healthcare poli...
(Date:12/2/2009)...e/ -- The Universities of Sassari and Cagliari (...ctors from the United States, announced today the ...ng that Pecorino cheese contains high amounts of C...turated fatty acid naturally found in certain food...humans. ,, The study, conducted in Sardinia, ...
(Date:12/2/2009)... -- Proving true the old adage that "The sum is gr...st Hospital Southlake (THHMHS) is partnering with ...am to make the holiday season a little brighter fo...ning their efforts to collect unwrapped toys and c...ulminating in a final event on Tuesday, December ...
(Date:12/2/2009)..., but risk is unclear , , WEDNESDAY, Dec...dence that the average cigarette is crawling with ...isease. , But as one spokesman for a tobacco co...en,t sure what, if any, hazard the germs pose. And...round us every day of our lives. , Still, the ...
Breaking Medicine News(10 mins):Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3Health News:Texas Health Harris Methodist Hospital Southlake Joins With U.S. Marine Corps Reserves Toys for Tots to Spread Holiday Cheer 2Health News:Smokers Inhaling Germs With Each Cigarette 2
...Products offer biologically safe water through poi...on, NEW YORK, June 3 Nephros, Inc., a medical,de...biting its Dual Stage,Ultrafilter products at the ...ss of the Nephros online,hemodiafiltration technol...
..., N.J., June 3 BD (Becton,Dickinson and Company) ...,announced today that it would present at the Gold...nference on Wednesday, June 11, 2008, at 4:20,p.m....r replay,through Wednesday, June 18, 2008., BD, a...
...N.J., June 3 HLTH Corporation,(Nasdaq: HLTH ) to...e,agreement to sell its ViPS segment to General Dy...d subsidiary of General Dynamics Corporation,(NYSE...d under the Hart-Scott-Rodino Act., ViPS provides...
...ells can produce tiny magnetic nuggets after the i...ists have found. The gene MagA could become a valu... body via magnetic resonance imaging (MRI), says X...to make mammalian cells have a magnetic signature,...
...., June 3 MedAmerica reports 2007 was its,17th co...sults. In,addition, MedAmerica outperformed the lo...years with a compound annual sales rate of 10%. (L...America,Insurance Company of Florida (Home Office:...
...June 3 On June 7, 2008 the Philadelphia,Physician...hensive,physicals for student athletes in the Phil...sylvania are required to receive a physical to be ...life-threatening conditions., The 2008 program wi...
Other Medicine News:Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 2Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 3Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 4Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 2Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 3Health News:Philly's Top Doc's Organize to Help Prevent Young Athlete Deaths in Philadelphia 2
(Date:12/2/2009)..., PLEASANTON, Calif., Dec. 2 /PRNewswire-FirstCal... today that the United States Food & Drug Admi...se for its licensed nucleic acid test, to screen s...dual donations. The test, called the cobas® T...tem, is a qualitative, in-vitro test for the simul...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewswire/...ing a late-breaking presentation on Tasigna® ...yeloid leukemia, demonstrate the strength of the c...e of patients. ,, The new data, at the 51st Am...and Exposition, highlight the company,s current th...
(Date:12/1/2009)..., REDONDO BEACH, Calif., Dec. 1 Re...their Elective Single Embryo Transfer (eSET) Encou...for patients with good embryo quality and a good p...ce of twins by transferring a single embryo. ,,...logy today is reducing the number of multiple preg...
Breaking Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Craneware Announces Fiscal Year End Results 56424 1Craneware Announces Fiscal Year End Results 56424 2Craneware Announces Fiscal Year End Results 56424 3Dr Smith Comes to Washington 3A Angry Physicians From All 50 States Rally in DC on Sept 10 56422 1Dr Smith Comes to Washington 3A Angry Physicians From All 50 States Rally in DC on Sept 10 56422 2Bipartisan Policy Center and Better Health Care Together to Host Joint Health Care Forum Tomorrow 56420 1Bipartisan Policy Center and Better Health Care Together to Host Joint Health Care Forum Tomorrow 56420 2
...all at 9:00 AM ET Today , , CORAL GABLES, Fla.,...asdaq: CPRX ) today announced top-line results f...ine addiction. The data from the trial showed tha...ance in the primary endpoint -- that a significant...han placebo-treated subjects were cocaine-free dur...
...nd Evidence of Biological Activity in 9 of 12 Pati...7 Leading U.S. Medical Centers , , SAN DIEGO, May...data from the Calcium Up-Regulation by Percutaneou...e (CUPID), a First-in-Human Phase 1/2 Clinical Tri...merican Society of Gene Therapy Meeting. , , Th...
Other Medicine Technology:Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 2Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 3Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 4Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 2Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 3Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 4
AXIOM CT Miyabi
Blade Holder
...ase of the World's First Hand-Held Autorefractor/K... for accuracy, reliability and performance Share t...th no wires to limit, you can use it virturally an...vanced measurement modes. Readings are taken the ...
Heartstring™
Medicine Products: